{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T04:51:36Z","timestamp":1778647896044,"version":"3.51.4"},"reference-count":31,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2010,10,14]],"date-time":"2010-10-14T00:00:00Z","timestamp":1287014400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vet Pharm &amp; Therapeutics"],"published-print":{"date-parts":[[2011,8]]},"abstract":"<jats:p>Schuller, S., Van Isra\u00ebl, N., Vanbelle, S., Clercx, C., McEntee, K. Lack of efficacy of low\u2010dose spironolactone as adjunct treatment to conventional congestive heart failure treatment in dogs.<jats:italic>J. vet. Pharmacol. Therap<\/jats:italic>.<jats:bold>34,<\/jats:bold>322\u2013331.<\/jats:p><jats:p>Aldosterone plays an important role in the pathophysiology of heart failure. Aldosterone receptor blockade has been shown to reduce morbidity and mortality in human patients with advanced congestive left ventricular heart failure. This study was designed to assess the efficacy and tolerance of long\u2010term low\u2010dose spironolactone when added to conventional heart failure treatment in dogs with advanced heart failure. Eighteen client\u2010owned dogs with advanced congestive heart failure due to either degenerative valve disease (<jats:italic>n<\/jats:italic>\u2003=\u200311) or dilated cardiomyopathy (<jats:italic>n<\/jats:italic>\u2003=\u20037) were included in this prospective, placebo\u2010controlled, double\u2010blinded, randomized clinical study. After initial stabilization including furosemide, angiotensin\u2010converting enzyme inhibitors, pimobendan and digoxin, spironolactone at a median dose of 0.52\u2003mg\/kg (range 0.49\u20130.8\u2003mg\/kg) once daily (<jats:italic>n<\/jats:italic>\u2003=\u20039) or placebo (<jats:italic>n<\/jats:italic>\u2003=\u20039) was added to the treatment, and the dogs were reassessed 3 and 6\u2003months later. Clinical scoring, echocardiography, electrocardiogram, systolic blood pressure measurement, thoracic radiography, sodium, potassium, urea, creatinine, alanine aminotransferase, aldosterone and aminoterminal atrial natriuretic propeptide were assessed at baseline, 3 and 6\u2003months. Survival times were not significantly different between the two treatment groups. Spironolactone was well tolerated when combined with conventional heart failure treatment.<\/jats:p>","DOI":"10.1111\/j.1365-2885.2010.01235.x","type":"journal-article","created":{"date-parts":[[2010,10,14]],"date-time":"2010-10-14T14:49:16Z","timestamp":1287067756000},"page":"322-331","source":"Crossref","is-referenced-by-count":11,"title":["Lack of efficacy of low\u2010dose spironolactone as adjunct treatment to conventional congestive heart failure treatment in dogs"],"prefix":"10.1111","volume":"34","author":[{"given":"S.","family":"SCHULLER","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"VAN ISRA\u00cbL","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"VANBELLE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"CLERCX","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"McENTEE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,10,14]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1760-2734(06)70025-X"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.2009.0467.x"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/heart.85.4.e8"},{"key":"e_1_2_8_5_1","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2460\/javma.1995.206.02.194","article-title":"Vertebral scale system to measure canine heart size in radiographs","volume":"206","author":"Buchanan J.W.","year":"1995","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.1997.tb00474.x"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198706043162301"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.1995.tb01075.x"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1080\/14017439850139816"},{"key":"e_1_2_8_10_1","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.2460\/javma.1998.213.11.1573","article-title":"Effects of enalapril maleate on survival of dogs with naturally acquired heart failure. The long\u2010term investigation of Veterinary Enalapril (LIVE) study group","volume":"213","author":"Ettinger S.J.","year":"1998","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2885.2009.01130.x"},{"key":"e_1_2_8_12_1","doi-asserted-by":"crossref","first-page":"698","DOI":"10.2460\/ajvr.1994.55.05.698","article-title":"Plasma concentration of atrial natriuretic peptide in relation to severity of mitral regurgitation in Cavalier King Charles Spaniels","volume":"55","author":"H\u00e4ggstr\u00f6m J.","year":"1994","journal-title":"American Journal of Veterinary Research"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000068340.96506.0F"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.1995.tb01074.x"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa040135"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.01186.2004"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1582-4934.2003.tb00197.x"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.2307\/2531201"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199807303390507"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.82.1.57"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1740-8261.1986.tb00001.x"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199909023411001"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)02382-3"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0894-7317(89)80014-8"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-5827.2005.tb00302.x"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejheart.2004.04.013"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000039104.56479.42"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.82.5.1730"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvc.2007.08.002"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.2460\/ajvr.2001.62.961"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2005.02.016"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.22.2700"}],"container-title":["Journal of Veterinary Pharmacology and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2885.2010.01235.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2885.2010.01235.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,31]],"date-time":"2024-03-31T11:01:21Z","timestamp":1711882881000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2885.2010.01235.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,14]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["10.1111\/j.1365-2885.2010.01235.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2885.2010.01235.x","archive":["Portico"],"relation":{},"ISSN":["0140-7783","1365-2885"],"issn-type":[{"value":"0140-7783","type":"print"},{"value":"1365-2885","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,14]]}}}